Suven Life gains 1.5% after securing two product patents

India Infoline News Service | Mumbai | October 18, 2016 16:56 IST

With these new patents, Suven has a total of twenty three granted patents from Europe and twelve granted patents from Israel.

Suven Life Sciences
Suven Life Sciences Ltd ended at Rs 197.2, up by Rs 3.05 or 1.57% from its previous closing of Rs 194.15 on the BSE after the company announced that it has granted one product patent from Europe and Israel corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029 and 2030 respectively.

The scrip opened at Rs 195 and touched a high and low of Rs 204.3 and Rs 195 respectively. A total of 602998(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 2471.19 crore.

The BSE group 'B' stock of face value Rs 1 touched a 52 week high of Rs 293.95 on 23-Oct-2015 and a 52 week low of Rs 144.35 on 19-Feb-2016. Last one week high and low of the scrip stood at Rs 201.9 and Rs 193.55 respectively.

The promoters holding in the company stood at 60 % while Institutions and Non-Institutions held 7.31 % and 32.69 % respectively.

The stock traded above its 200 DMA.

***Note: This is a NSE Chart



  • Get your free IIFL Demat & Trading A/c now...Click here
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.